Who makes CAL02 Low-dose?

CAL02 Low-dose is developed by Combioxin SA.

Last reviewed 2026-04-20 · How we verify

CAL02 Low-dose

Combioxin SA · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	CAL02 Low-dose
Also known as	CAL02 LD
Sponsor	Combioxin SA
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CAL02 Low-dose CI brief — competitive landscape report
CAL02 Low-dose updates RSS · CI watch RSS
Combioxin SA portfolio CI